Company intelligence / Profile preview
UPyTher
Eindhoven, North Brabant, The Netherlandsupyther.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
UPyTher is developing a drug delivery platform that converts to a soft, elastic gel inside the body, increasing dwell time and exposure of active drugs in the peritoneal cavity. Their technology aims to improve therapeutic effects of existing drugs as intraperitoneal therapy[1][5].
- Therapeutic areas
- Oncology
- Modalities
- Custom drug delivery solutions
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Specipig (for development)[7]
Beyond the preview
Go deeper on UPyTher.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UPyTher.